CIDEA (Cell Death-Inducing DFFA-Like Effector A) is a member of the CIDE (Cell Death-Inducing DFFA-like Effector) family of proteins that play important roles in regulating cell death, lipid metabolism, and energy homeostasis. The gene is located on chromosome 18p11.21 and encodes a protein primarily associated with lipid droplets in cells. [1] CIDEA is highly expressed in brown adipose tissue, where it promotes lipid droplet formation and regulates thermogenesis. The protein is also expressed in the liver and other tissues, where it influences metabolic processes.
Beyond its well-characterized role in metabolic tissues, CIDEA has emerging relevance to neurodegenerative diseases. The brain relies on lipid metabolism for proper neuronal function, and dysregulated lipid homeostasis is a hallmark of Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions. [2] This page covers CIDEA's normal functions, disease associations, expression patterns, and potential implications for neurodegeneration.
CIDEA is a 175-amino acid protein with a unique structure characterized by a CIDE-N domain at the N-terminus and a CIDE-C domain at the C-terminus. These domains are shared with other CIDE family members (CIDEB and CIDEC/FSP27) and are involved in protein-protein interactions and lipid droplet targeting. [3]
The CIDE-N domain (approximately 80 amino acids) mediates homodimerization and heterodimerization with other CIDE family members. This dimerization is essential for the protein's lipid droplet localization and function. The CIDE-C domain (~70 amino acids) interacts with various binding partners and contributes to the protein's pro-apoptotic activity. [4]
CIDEA is primarily localized to lipid droplets, which are dynamic organelles storing neutral lipids including triglycerides and cholesterol esters. The protein localizes to the surface of lipid droplets through interactions with the phospholipid monolayer. In addition to lipid droplets, CIDEA can also be found in the cytoplasm and, under certain conditions, in the nucleus. [5]
The lipid droplet localization of CIDEA is dynamic and regulated by nutritional status, hormonal signals, and cellular stress. During fasting, CIDEA expression increases and promotes lipid droplet accumulation, while in the fed state, the protein may be downregulated to facilitate lipid mobilization. [6]
Originally identified as a regulator of apoptosis, CIDEA interacts with the Fas receptor and inhibits apoptosis in certain cellular contexts. The protein can associate with DFF45 (DNA fragmentation factor subunit beta), an inhibitor of CAD (caspase-activated DNase), thereby modulating the apoptotic cascade. [3:1]
However, the pro-apoptotic versus anti-apoptotic functions of CIDEA appear to be context-dependent. In some settings, CIDEA promotes cell death, while in others it provides survival advantages. This duality reflects the protein's complex interactions with multiple signaling pathways. [7]
CIDEA plays a central role in lipid metabolism, particularly in brown adipose tissue (BAT). Brown fat is specialized for non-shivering thermogenesis, generating heat through uncoupled mitochondrial respiration. CIDEA promotes lipid droplet formation and accumulation in brown adipocytes, providing substrate for thermogenesis. [8]
The protein interacts with uncoupling protein 1 (UCP1) in the mitochondrial inner membrane to enhance proton leak and heat production. Studies in mice have shown that CIDEA overexpression in white adipose tissue induces "browning" - the conversion of white adipocytes to brown-like cells with increased thermogenic capacity. [9]
In the liver, CIDEA regulates lipid droplet dynamics and contributes to hepatic lipid homeostasis. Loss of CIDEA in mice leads to hepatic steatosis (fatty liver), decreased VLDL (very-low-density lipoprotein) secretion, and premature death when combined with CIDEB knockout. [5:1]
CIDEA affects hepatic lipid metabolism through multiple mechanisms:
Recent research has revealed that CIDEA plays a role in regulating autophagy, the cellular recycling process that degrades damaged organelles and protein aggregates. CIDEA can interact with autophagy-related proteins and influence the formation of autophagosomes. In cancer cells, CIDEA has been shown to regulate autophagy and lipid metabolism through AMPK signaling. [10]
This function has implications for neurodegeneration, where impaired autophagy contributes to the accumulation of toxic protein aggregates.
The brain contains lipid droplets that accumulate in neurons and glia under various pathological conditions. In Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders, lipid droplet accumulation is increasingly recognized as a key pathological feature. [11]
Several mechanisms contribute to lipid droplet accumulation in neurodegeneration:
CIDEA, as a lipid droplet-associated protein, may influence these processes and contribute to or protect against neurodegeneration. [12]
Alzheimer's disease is characterized by amyloid-beta (Aβ) plaques, neurofibrillary tangles composed of hyperphosphorylated tau, and progressive neuronal loss. Lipid metabolism dysfunction is increasingly recognized as an important contributor to AD pathogenesis. [13]
In AD brains, altered expression of lipid droplet-associated proteins has been reported, potentially affecting Aβ metabolism, tau phosphorylation, and neuronal survival. While direct evidence for CIDEA involvement in AD is limited, the protein's functions in lipid metabolism and autophagy suggest potential relevance. Studies have shown that improving lipid droplet dynamics can protect against Aβ toxicity in cellular models. [14]
The APOE ε4 allele, the major genetic risk factor for late-onset AD, is involved in lipid transport and metabolism, highlighting the importance of lipid homeostasis in AD pathogenesis. CIDEA and other lipid droplet proteins may interact with APOE-related pathways. [15]
Parkinson's disease is characterized by loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies composed of α-synuclein. Lipid metabolism alterations have been implicated in PD pathogenesis, and lipid droplets accumulate in affected brain regions. [16]
CIDEA may influence PD pathogenesis through effects on:
In ALS, lipid droplet accumulation has been observed in motor neurons and surrounding glia. The protein TDP-43 forms cytoplasmic inclusions in most ALS cases, and lipid metabolism alterations may affect TDP-43 aggregation and toxicity. [17]
Several pathways connect CIDEA to neurodegeneration:
Autophagy and protein clearance: CIDEA's role in autophagy regulation could affect clearance of toxic protein aggregates (Aβ, tau, α-synuclein, TDP-43).
Mitochondrial function: CIDEA influences mitochondrial metabolism and could affect neuronal energy homeostasis and oxidative stress resistance.
Neuroinflammation: Lipid droplet accumulation in glial cells promotes inflammatory responses. CIDEA expression in immune cells could modulate neuroinflammation. [18]
Oxidative stress: Lipid droplets both sequester and generate reactive oxygen species (ROS). CIDEA may influence oxidative stress in neurons through lipid droplet dynamics. [19]
| Tissue | Expression Level | Notes |
|---|---|---|
| Brown adipose tissue | Highest | Primary site of expression |
| Liver | High | Regulation of hepatic lipid metabolism |
| Brain | Low-Moderate | Neurons and glia |
| Heart | Moderate | Cardiac lipid metabolism |
| Kidney | Low | Minor expression |
In the brain, CIDEA is expressed in various regions including the cortex, hippocampus, and cerebellum. The protein is present in both neurons and glial cells, with potential upregulation under pathological conditions. [12:1]
Human genetic studies have linked CIDEA variants to obesity and metabolic traits. The CIDEA gene is considered a candidate gene for obesity susceptibility, with certain polymorphisms associated with increased body mass index (BMI) and altered lipid profiles. [6:1]
CIDEA dysregulation has been implicated in NAFLD, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). The protein's role in hepatic lipid droplet formation and VLDL secretion influences the development and progression of fatty liver disease. [5:2]
Alterations in CIDEA expression have been reported in various cancers. The protein can function as a tumor suppressor in some contexts, while in others it may support tumor progression. CIDEA affects cancer cell metabolism, proliferation, and survival through lipid metabolism and apoptosis regulation. [10:1]
Based on the protein's functions in lipid metabolism and autophagy, CIDEA may be relevant to:
Direct evidence establishing CIDEA as a driver or modifier of these conditions is limited and requires further investigation.
Given CIDEA's central role in energy metabolism, the protein represents a potential therapeutic target for obesity and related metabolic disorders. Strategies to modulate CIDEA activity include:
Understanding CIDEA's role in brain lipid metabolism could reveal new therapeutic approaches for neurodegenerative diseases:
However, direct evidence for CIDEA-targeted therapies in neurodegeneration is currently limited and requires further research.
Lough et al. Cloning and chromosomal mapping of human CIDEA and CIDEB genes. Cytogenetics and Genome Research. 1999. ↩︎
Li et al. Lipid droplet proteins and neurodegenerative diseases. Progress in Lipid Research. 2019. ↩︎
Inohara et al. CIDEA, a novel homolog of Drosophila DFF-45, associates with Fas and inhibits apoptosis. Journal of Biological Chemistry. 1999. ↩︎ ↩︎ ↩︎
Zhou et al. The emerging role of CIDEA in lipid metabolism and disease. Journal of Molecular Cell Biology. 2013. ↩︎ ↩︎
Pospischil et al. Loss of CIDEA and CIDEB in mice leads to hepatic steatosis and death. Cell Metabolism. 2009. ↩︎ ↩︎ ↩︎ ↩︎
Barnett et al. CIDEA is associated with lipid metabolism and obesity in humans. Obesity. 2016. ↩︎ ↩︎ ↩︎
Liu et al. CIDEA in cellular stress and apoptosis. Cell Death and Disease. 2022. ↩︎
Gonzalez et al. Brown adipose tissue: function and therapeutic potential in metabolic disease. Nature Reviews Endocrinology. 2019. ↩︎ ↩︎
Wang et al. Brown fat CIDEA promotes mitochondrial uncoupling and thermogenesis. Journal of Lipid Research. 2018. ↩︎
Chen et al. CIDEA regulates autophagy and lipid metabolism in cancer cells. Autophagy. 2019. ↩︎ ↩︎ ↩︎
Gao et al. The role of lipid droplets in neurodegeneration. Biochimica et Biophysica Acta - Molecular Basis of Disease. 2020. ↩︎ ↩︎
Tol et al. CIDEA and lipid metabolism in the brain: implications for Alzheimer's disease. Journal of Alzheimer's Disease. 2018. ↩︎ ↩︎
Jiang et al. Lipid metabolism dysfunction in Alzheimer's disease: from mechanisms to therapy. Signal Transduction and Targeted Therapy. 2022. ↩︎
Liu et al. Lipid droplet accumulation in neurodegenerative diseases. Frontiers in Neuroscience. 2020. ↩︎
Yun et al. Cellular lipid metabolism in neurons and glia: implications for neurodegeneration. Neurochemical Research. 2019. ↩︎
Ikeda et al. Lipid droplets in brain physiology and disease. Cellular and Molecular Neurobiology. 2019. ↩︎
Yang et al. Lipid droplet dynamics in neuronal health and disease. Trends in Neurosciences. 2021. ↩︎
Marschall et al. CIDEA expression and function in immune cells. Journal of Immunology. 2019. ↩︎ ↩︎
Zhang et al. Lipid droplets and oxidative stress in neurodegeneration. Oxidative Medicine and Cellular Longevity. 2021. ↩︎